Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Pediatr ; 129(2): 264-8, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8765625

RESUMEN

OBJECTIVES: To determine the degree of clotting activation that occurs with the usual anticoagulation regimen with systemic heparinization. METHODS: To allow a standardized comparison of the patients, this study focused on the first 48 hours of extracorporeal membrane oxygenation (ECMO) in term newborn infants. The ECMO perfusion circuit consisted of a roller pump, silicone membrane lungs, and silicone rubber tubing. Coagulation was controlled routinely by measuring prothrombin time, fibrinogen, antithrombin III, and reptilase time. Platelet counts, activated clotting time, and heparin concentration were controlled regularly. The following specific activation markers of the clotting system were measured: prothrombin activation fragment 1 + 2(F1+2), thrombin-antithrombin III complexes, and D-dimer. Measurements were done before the start of ECMO, after 5 minutes, and at hours 1, 2, 3, 4, 6, 12, 24 and 48. RESULTS: All seven term infants had excessively high levels of clotting activation markers within the first 2 hours of ECMO: F1+2, 11.6(+/- O.9) nmol/L (mean +/- SEM); thrombin-antithrombin, 920(+/- 2.2) microg/L; D-dimer, 15.522(+/- 3.689) ng/L. During the next 46 hours of ECMO, F1+2 and thrombin-antithrombin III complexes decreased from those high values, whereas D-dimer did not. The increase of activation markers was accompanied by low fibrinogen, low platelet counts. and prolongation of reptilase time. CONCLUSIONS: These findings fit the pattern of consumptive coagulopathy during neonatal ECMO, especially in the first 24 hours.


Asunto(s)
Coagulación Sanguínea , Oxigenación por Membrana Extracorpórea , Recién Nacido/sangre , Anticoagulantes/administración & dosificación , Anticoagulantes/uso terapéutico , Antitrombina III/análisis , Batroxobina/sangre , Diseño de Equipo , Oxigenación por Membrana Extracorpórea/instrumentación , Productos de Degradación de Fibrina-Fibrinógeno/análisis , Fibrinógeno/análisis , Estudios de Seguimiento , Heparina/administración & dosificación , Heparina/uso terapéutico , Humanos , Intubación/instrumentación , Membranas Artificiales , Fragmentos de Péptidos/análisis , Péptido Hidrolasas/análisis , Recuento de Plaquetas , Protrombina/análisis , Tiempo de Protrombina , Elastómeros de Silicona , Siliconas , Tiempo de Coagulación de la Sangre Total
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA